Demand for weight-loss medications balances price pressure, and Lilly increases its profit prediction
Strong demand for Lilly's GLP-1 weight-loss and diabetes medications helped offset declining prices in U.S. and foreign markets. Causing the...
Health
Eli Lilly plans to pay up to $7 billion to purchase Kelonia Therapeutics
Eli Lilly, a U.S. pharmaceutical corporation, and Kelonia Therapeutics, a privately held biotechnology business. Reached an agreement on Monday to...
Eli Lilly’s weight-loss pill has received FDA approval
Eli Lilly's new GLP-1 medication for weight loss, Foundayo, has received FDA approval. After Novo Nordisk's Wegovy was approved last...
Moderna shares rise 6% after the FDA reversed its decision not to review the flu vaccine
Following an earlier surge in pre-market trading, Moderna shares increased 6.4% to approximately $46.75 shortly after the market started on...
Eli Lilly lowers the cost of its weight-loss medication, Zepbound
Eli Lilly dropped the cost of Zepbound on Monday after the pharmaceutical giant and Ozempic producer Novo Nordisk reached an...
Ozempic’s monthly cost significantly decreases following the Trump deal
Following President Donald Trump's announcement of a deal with pharmaceutical companies to lower the cost of two well-known medications in...
OpenAI is exploring developing consumer health products as it extends beyond basic AI
OpenAI is considering developing consumer health products, including a personal health assistant powered by generative AI, as the creator of...
Linda Yaccarino, who was formerly CEO of Musk X, is now leading the digital health firm eMed
Nearly a month after departing from her role as CEO of social media platform X, Linda Yaccarino is set to...
Juul is set to obtain U.S. regulatory approval for its e-cigarettes
The company announced to Forbes on Thursday that Juul will be granted approval from the Food and Drug Administration (FDA)...
Bristol Myers to pay $1.5 billion dollars, upfront, in conjunction with BioNTech for cancer medicine
In a deal that could be worth over 11 billion dollars for the German company, Bristol Myers Squibb announced Monday...
